-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602.O1.6 602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Altered Splicing and Transcriptional Regulation

Program: Oral and Poster Abstracts
Type: Oral
Monday, December 3, 2018: 4:30 PM-6:00 PM
Room 9 (San Diego Convention Center)
Moderators:
Vincenzo Giambra, PhD, Fondazione IRCCS Casa Sollievo della Sofferenza and Panagiotis Ntziachristos, PhD, Northwestern University, Feinberg School of Medicine
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Meenakshi Venkatasubramanian, BS1*, Xiaoting Chen, Ph.D.2*, Kashish Chetal, MS1*, Aishwarya Kulkarni, MS1*, Kasiani C. Myers, MD3, Matthew T. Weirauch, Ph.D.1,2*, H. Leighton Grimes, Ph.D.4 and Nathan Salomonis, Ph.D.1*

1Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
3Bone Marrow Transplantation & Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, OH
4Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

4:45 PM

Jisha Antony, PhD1*, Gregory Giminez, PhD2*, Umaima Khatoon, BSc (Hons)2*, Robert Day, PhD3*, Ian Morison, PhD, FRCPA, MBBS2* and Julia Horsfield, PhD2*

1Department of Pathology, University of Otago, Dunedin, Otago, New Zealand
2Department of Pathology, University of Otago, Dunedin, New Zealand
3Department of Biochemistry, University of Otago, Dunedin, New Zealand

5:00 PM

Shiva Bamezai, PhD1*, Naidu Vegi, PhD2*, Alex Pulikkottil Jose2*, Julia Müller, BSc.2*, Ingrid Grummt3*, Chenlin Song, PhD3*, Konstanze Döhner, MD4*, Hartmut Döhner, MD5*, Michaela Feuring-Buske, MD2,4*, Vijay Pal Singh Rawat, PhD2* and Christian Buske, MD2

1Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Neu Ulm, Germany
2Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany
3Molecular Biology of the Cell II, German Cancer Research Center (DKFZ), DKFZ-Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH) Alliance, D-69120, Heidelberg, Germany
4Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
5Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

5:15 PM

Hengyou Weng, PhD1, Huilin Huang, PhD2, Huizhe Wu3*, Mingli Sun4*, Savanna Stanford4*, Sean Robinson1*, zhen-Hua Chen4*, Xi Qin5*, Xiaolan Deng1*, Xi Jiang, PhD5, Ying Qing4*, Chao Shen, PhD5*, Rui Su, PhD5, Minjie Wei6* and Jianjun Chen, PhD1

1Department of Systems Biology, Beckman Research Institute, City of Hope Medical Center, Monrovia, CA
2Department of Systems Biology, City of Hope, Duarte, CA
3China Medical University, Shenyang, China
4City of Hope, Duarte
5Department of Cancer Biology, University of Cincinnati, Cincinnati
6China Medical University, Shenyang

5:30 PM

Jenny L. Smith, MSc, MEd1*, Rhonda E. Ries, MA1*, Marianne T. Santaguida, BSc, PhD2*, Christos Gekas, PhD3*, Todd A Alonzo, PhD4,5,6*, Robert B Gerbing, MA4*, Alan S Gamis, MD, MPH7, Richard Aplenc, MD, PhD8, E. Anders Kolb, MD4,9, Tiffany Hylkema, BS1*, Lisa Eidenschink Brodersen, PhD10, Michael R. Loken, PhD10*, Hamid Bolouri, Ph.D.11* and Soheil Meshinchi, MD, PhD4,12,13

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Notable Laboratories, San Francisco, CA
3Notable Labs, Foster City, CA
4Children's Oncology Group, Monrovia, CA
5Division of Biostatistics, University of Southern California, Los Angeles, CA
6Children’s Oncology Group, Department of Preventive Medicine, University of Southern California, Monrovia, CA
7Children's Mercy Cancer Center, Kansas City, MO
8Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia
9Nemours Alfred I. duPont Hospital for Children, Wilmington, DE
10Hematologics Inc, Seattle, WA
11Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle
12Department of Pediatrics, University of Washington, Seattle
13Clinical Research Division, Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA

5:45 PM

Akihide Yoshimi, MD, PhD1*, Zhaoqi Liu, PhD2*, Wang Jiguang3*, Hana Cho, MSc1*, Stanley C Lee, PhD1, Michelle Ki, BSc1*, Lillian E Bitner, BSc1*, Timothy Chu2*, Anthony R Mato, MD4, Peter P. Ruvolo, PhD5, Giulia Fabbri6*, Laura Pasqualucci, MD6, Raul Rabadan, PhD2* and Omar I Abdel-Wahab, MD7,8

1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Systems Biology, Columbia University, New York, NY
3Hong Kong University of Science and Technology, Hong Kong, China
4Memorial Sloan Kettering Cancer Center, New York, NY
5Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX
6Institute for Cancer Genetics, Columbia University, New York, NY
7Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY
8Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH